GI Cancer
Advertisement
A meta-analysis of randomized clinical trials suggests the combination could reshape established treatment paradigms.
Researchers studied the impact of using the explain‑simulate‑practice‑communication‑support model of nursing.
Fear of cancer recurrence is considered one of the most common unmet needs reported by patients with cancer.
The extent of muscle mass loss varied depending on the type of tumor and treatment.
Lisa A. Hall, MHA, CDP, of the Colorectal Cancer Alliance, speaks about the importance of Colorectal Cancer Awareness Month.
Learn how nurses can help patients understand their risk factors and find a screening option that is right for them.
While the approval of any new drug for pancreatic cancer is exciting, it's important for nurses to understand the nuances.
February is Gallbladder and Bile Duct Cancer Awareness Month, a time to draw attention to this often-overlooked cancer.
An online quiz provided over 30,000 CRC screening recommendations from July 2022-August 2023.
Researchers uncovered a "particularly pronounced" link between early-onset rectal cancer and a certain "red flag" sign.
Results of a recent study show why “nursing care of patients with CRC stoma should not be ignored."
Learn how lavender oil can help with odor management, ostomy adjustment, and quality-of-life outcomes in these patients.
Martha Raymond, MS, of the GI Cancers Alliance, speaks about the important role that oncology nurses play in GI cancer care.
Psychosocial care and support are critical parts of cancer care, according to the International Psycho-Oncology Society.
Timothy Brown, MD, discusses research on the treatment strategy at the 2024 ASCO GI Cancers Symposium.
Certain patients are less likely to use hospice services, but oncology nurses can help ensure the option is made available.
MATTERHORN is the “first study to attempt to standardize therapy perioperatively with FLOT,” Dr. Janjigian said.
Martha Raymond, MA, discusses eye-opening findings from a study presented at the 2024 ASCO GI Cancers Symposium.
Jessica A. Zerillo, MD, MPH, discusses research on the tool that she presented at the 2024 ASCO GI Cancer Symposium.
Researchers wanted to understand how patients perceive the utility of ctDNA testing and how it affects fear of recurrence.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.